In a unanimous ruling, the Supreme Court of the United States (SCOTUS) has rejected a bid to restrict people's access to the widely used abortion pill mifepristone. The drug is one half of a two-pill regimen prescribed for medication abortions, which made up more than 60% of all abortions in the U.S. last year.
The plaintiffs in the case were members of the Alliance for Hippocratic Medicine (AHM), a collective of anti-abortion groups that includes doctors. The defendant was the Food and Drug Administration (FDA).
